Menon Poornima Jayadev, Sambin Sara, Criniere-Boizet Baptiste, Courtin Thomas, Tesson Christelle, Casse Fanny, Ferrien Melanie, Mariani Louise-Laure, Carvalho Stephanie, Lejeune Francois-Xavier, Rebbah Sana, Martet Gaspard, Houot Marion, Lanore Aymeric, Mangone Graziella, Roze Emmanuel, Vidailhet Marie, Aasly Jan, Gan Or Ziv, Yu Eric, Dauvilliers Yves, Zimprich Alexander, Tomantschger Volker, Pirker Walter, Álvarez Ignacio, Pastor Pau, Di Fonzo Alessio, Bhatia Kailash P, Magrinelli Francesca, Houlden Henry, Real Raquel, Quattrone Andrea, Limousin Patricia, Korlipara Prasad, Foltynie Thomas, Grosset Donald, Williams Nigel, Narendra Derek, Lin Hsin-Pin, Jovanovic Carna, Svetel Marina, Lynch Timothy, Gallagher Amy, Vandenberghe Wim, Gasser Thomas, Brockmann Kathrin, Morris Huw R, Borsche Max, Klein Christine, Corti Olga, Brice Alexis, Lesage Suzanne, Corvol Jean Christophe
Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France.
Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
NPJ Parkinsons Dis. 2024 Mar 29;10(1):72. doi: 10.1038/s41531-024-00677-3.
Bi-allelic pathogenic variants in PRKN are the most common cause of autosomal recessive Parkinson's disease (PD). 647 patients with PRKN-PD were included in this international study. The pathogenic variants present were characterised and investigated for their effect on phenotype. Clinical features and progression of PRKN-PD was also assessed. Among 133 variants in index cases (n = 582), there were 58 (43.6%) structural variants, 34 (25.6%) missense, 20 (15%) frameshift, 10 splice site (7.5%%), 9 (6.8%) nonsense and 2 (1.5%) indels. The most frequent variant overall was an exon 3 deletion (n = 145, 12.3%), followed by the p.R275W substitution (n = 117, 10%). Exon3, RING0 protein domain and the ubiquitin-like protein domain were mutational hotspots with 31%, 35.4% and 31.7% of index cases presenting mutations in these regions respectively. The presence of a frameshift or structural variant was associated with a 3.4 ± 1.6 years or a 4.7 ± 1.6 years earlier age at onset of PRKN-PD respectively (p < 0.05). Furthermore, variants located in the N-terminus of the protein, a region enriched with frameshift variants, were associated with an earlier age at onset. The phenotype of PRKN-PD was characterised by slow motor progression, preserved cognition, an excellent motor response to levodopa therapy and later development of motor complications compared to early-onset PD. Non-motor symptoms were however common in PRKN-PD. Our findings on the relationship between the type of variant in PRKN and the phenotype of the disease may have implications for both genetic counselling and the design of precision clinical trials.
PRKN基因的双等位基因致病性变异是常染色体隐性帕金森病(PD)的最常见病因。这项国际研究纳入了647例PRKN-PD患者。对所存在的致病性变异进行了特征分析,并研究了其对表型的影响。还评估了PRKN-PD的临床特征和病程。在索引病例(n = 582)的133个变异中,有58个(43.6%)结构变异、34个(25.6%)错义变异、20个(15%)移码变异、10个剪接位点变异(7.5%)、9个(6.8%)无义变异和2个(1.5%)插入缺失变异。总体上最常见的变异是外显子3缺失(n = 145,12.3%),其次是p.R275W替代(n = 117,10%)。外显子3、RING0蛋白结构域和泛素样蛋白结构域是突变热点,分别有31%、35.4%和31.7%的索引病例在这些区域出现突变。移码变异或结构变异的存在分别与PRKN-PD发病年龄提前3.4±1.6岁或4.7±1.6岁相关(p < 0.05)。此外,位于蛋白质N端的变异(该区域富含移码变异)与发病年龄提前相关。PRKN-PD的表型特征为运动进展缓慢、认知功能保留、对左旋多巴治疗有良好的运动反应以及与早发型PD相比运动并发症出现较晚。然而,非运动症状在PRKN-PD中很常见。我们关于PRKN变异类型与疾病表型之间关系的研究结果可能对遗传咨询和精准临床试验的设计都有影响。